PRINCETON, N.J., Jan. 10, 2012 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced changes to its Board of Directors and executive management.
Effective January 1, 2012, Jess Jones, M.D. has been named Chief Executive Officer of the company, replacing Vincent W. Renz, Jr. Dr. Jones has been a member of the Company's Board of Directors since December 2008. From 2006 to December 2010 Dr. Jones worked with Vision Capital Advisors, LLC in New York City as the Director of Healthcare Investing, analyzing investment opportunities in the biotechnology, pharmaceutical, medical technology, and medical services fields, and assisted companies in implementing their business plans. From 2001 to 2007, Dr. Jones attended Columbia College of Physicians & Surgeons in New York City, where he received his medical degree in May 2007. Additionally, Dr. Jones earned a BA degree from the University of Utah in 2001 and an MBA from Columbia Business School in May 2007.
In addition, Greg Sadowski has been named Chief Operating Officer of the company. Mr. Sadowski has served as Senior Vice President, Client Services for NewCardio since October 2008. In that position, he has been responsible for preparing, delivering and supporting the NewCardio cardiovascular diagnostic technology solutions, including the Professional Services, Information Technology, Customer Care and Quality Assurance groups. From October 1997 to October 2008, Mr. Sadowski worked with eResearchTechnology (eRT), where he served on the Executive Management Team as Senior VP of eRT's Electronic Patient Reported Outcomes (ePRO) business.
Simultaneously, Mr. Renz, Patrick Maguire, M.D., Ph.D., and Mark W. Kroll, Ph.D, FACC, FHRS, resigned from the Company's Board of Directors. Also effective January 1, Richard D. Brounstein has resigned from the office of Chief Financial Officer of the Company. Both Mr. Renz and Mr. Brounstein will continue t
|SOURCE NewCardio, Inc.|
Copyright©2010 PR Newswire.
All rights reserved